Supriya Lifesci.

{
  "main_header": {
    "sid": 1003587,
    "name": "Supriya Lifesci.",
    "stock_name": "Supriya Lifesci.",
    "full_name": "Supriya Lifescience Ltd",
    "name_url": "stocks-analysis/supriya-lifesci",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "907.05",
    "chg": 51.85,
    "chgp": "6.06%",
    "dir": 1,
    "prev_price": "855.20",
    "mcapval": "7,300.19 Cr",
    "mcap": "Small Cap",
    "scripcode": 543434,
    "symbol": "SUPRIYA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE07RO01027",
    "curr_date": "Sep 07, 03:15 PM",
    "curr_time": "15:17 PM",
    "last_traded_at": "Sep 07, 03:15 PM IST",
    "bse_nse_vol": "11.6 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 07, 2026",
    "traded_date_str": "2026 09 07",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/supriya-lifesci-1003587-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Supriya Lifescience Ltd Surges 7.72% to Day's High of Rs 891.6 — Outperforms Sector by 4.25 Percentage Points",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-hits-intraday-high-with-772-surge-on-7-sep-2026-4184334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_priceRelatedfactors_4184334.png",
        "date": "2026-09-07 09:33:00",
        "description": "The Sensex declined 0.26% on 7 Sep 2026, while Supriya Lifescience Ltd surged 7.72%, marking a 4.25 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally."
      },
      {
        "title": "Supriya Lifescience Gains 6.40%: Technical Momentum and Mixed Financials Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-gains-640-technical-momentum-and-mixed-financials-shape-the-week-4183386",
        "imagepath": "",
        "date": "2026-09-05 12:00:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>31 Aug:</strong> Technical momentum shifts amid mixed indicator signals</p>\n                    <p><strong>1 Sep:</strong> Upgraded to Hold as technicals improve despite mixed financials</p>\n                    <p><strong>4 Sep:</strong> Week closes at Rs.855.20, up 6.40% for the week</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.799.40</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.855.20</div><div class=\"stat-change positive\">+6.40%</div></div>\n                    <div class=\"..."
      },
      {
        "title": "Supriya Lifescience Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-4177231",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/SupriyaLifescie_mojoScore_4177231.png",
        "date": "2026-09-01 08:57:08",
        "description": "Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s strong management efficiency, net-debt-free status, and growing institutional participation have contributed to a more balanced outlook for investors."
      },
      {
        "title": "Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4175419",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SupriyaLifescie_technicaldot_4175419.png",
        "date": "2026-08-31 08:03:02",
        "description": "Supriya Lifescience Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse."
      },
      {
        "title": "Supriya Lifescience’s Technical Shift and Downgrade Weigh on Stock Despite Long-Term Strength",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifesciences-technical-shift-and-downgrade-weigh-on-stock-despite-long-term-strength-4174062",
        "imagepath": "",
        "date": "2026-08-29 11:02:29",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>24 Aug:</strong> Stock opens at Rs.797.00, declines 0.99%</p>\n                    <p><strong>25 Aug:</strong> Downgrade to Sell announced; stock falls 0.72%</p>\n                    <p><strong>26 Aug:</strong> Technical momentum shift noted; stock drops 1.06%</p>\n                    <p><strong>27 Aug:</strong> Continued weakness; stock declines 0.86%</p>\n                    <p><strong>28 Aug:</strong> Strong recovery; stock surges 3.55%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.805.00</div></div>\n                    <div class=\"stat-item\"><div class..."
      },
      {
        "title": "Supriya Lifescience Downgraded to Sell Amid Technical and Financial Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-downgraded-to-sell-amid-technical-and-financial-setbacks-4169619",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SupriyaLifescie_mojoScore_4169619.png",
        "date": "2026-08-26 08:29:55",
        "description": "Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 Aug 2026. This change reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quality metrics and institutional interest."
      },
      {
        "title": "Supriya Lifescience Ltd Faces Technical Momentum Shift Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-ltd-faces-technical-momentum-shift-amid-mixed-indicators-4169494",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SupriyaLifescie_technicaldot_4169494.png",
        "date": "2026-08-26 08:05:16",
        "description": "Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture, with bearish signals emerging on weekly and monthly charts, while some daily metrics maintain mild bullishness. This nuanced development comes amid a modest decline in the stock price and a downgrade in its Mojo Grade from Hold to Sell, reflecting growing caution among investors."
      },
      {
        "title": "Supriya Lifescience Gains 1.62%: 6 Key Factors Driving the Week’s Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/supriya-lifescience-gains-162-6-key-factors-driving-the-weeks-momentum-4165037",
        "imagepath": "",
        "date": "2026-08-22 11:02:26",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>17 Aug:</strong> Technical setback amid price momentum shift, stock closes at ₹784.00 (-1.04%)</p>\n                    <p><strong>18 Aug:</strong> Mixed momentum signals with sideways consolidation, stock rises to ₹802.30 (+2.33%)</p>\n                    <p><strong>19 Aug:</strong> Technical momentum shifts to mildly bullish, stock surges to ₹812.65 (+3.21%)</p>\n                    <p><strong>20 Aug:</strong> Bearish signals emerge, stock dips to ₹787.35 (-1.86%)</p>\n                    <p><strong>21 Aug:</strong> Mojo rating upgraded to Hold amid mixed signals, stock closes at ₹805.00 (+1.62%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                   ..."
      },
      {
        "title": "Supriya Lifescience Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/supriya-lifescience-ltd-upgraded-to-hold-amid-mixed-financial-and-technical-signals-4163497",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/SupriyaLifescie_mojoScore_4163497.png",
        "date": "2026-08-21 08:22:15",
        "description": "Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 20 August 2026, reflecting a nuanced shift in its financial performance, valuation, and technical outlook. Despite recent quarterly setbacks, the company’s long-term returns and institutional interest have supported a more balanced view, prompting analysts to revise their stance cautiously."
      }
    ],
    "total": 386,
    "sid": "1003587",
    "stock_news_url": "https://www.marketsmojo.com/news/supriya-lifescience-1003587"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "02-Sep-2026",
      "details": "Copy of Newspaper Public for dispatch of AGM Notice and Annual Report.",
      "source": "BSE"
    },
    {
      "caption": "Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015.",
      "datetime": "02-Sep-2026",
      "details": "Enclosed herewith disclosure under Regulation 30.",
      "source": "BSE"
    },
    {
      "caption": "Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company",
      "datetime": "02-Sep-2026",
      "details": "Enclosed herewith is the copy of Letter dispatched to shareholders whose email ids are not registered.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Supriya Lifescience Ltd has declared <strong>50%</strong> dividend, ex-date: 04 Sep 26",
          "dt": "2026-09-04",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Supriya Lifescience Ltd Surges 7.72% to Day's High of Rs 891.6 — Outperforms Sector by 4.25 Percentage Points

2026-09-07 09:33:00

The Sensex declined 0.26% on 7 Sep 2026, while Supriya Lifescience Ltd surged 7.72%, marking a 4.25 percentage-point outperformance over its Pharmaceuticals & Biotechnology sector. This strong single-session gain stands out amid a broadly weak market backdrop, signalling a stock-specific momentum shift rather than a general market rally.

Read full news article

Supriya Lifescience Gains 6.40%: Technical Momentum and Mixed Financials Shape the Week

2026-09-05 12:00:48

Key Events This Week

31 Aug: Technical momentum shifts amid mixed indicator signals

1 Sep: Upgraded to Hold as technicals improve despite mixed financials

4 Sep: Week closes at Rs.855.20, up 6.40% for the week

Week Open

Rs.799.40

Week Close

Rs.855.20

+6.40%

Read full news article

Supriya Lifescience Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-09-01 08:57:08

Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 31 August 2026, reflecting a nuanced improvement across technical indicators, valuation metrics, financial trends, and quality parameters. Despite recent quarterly setbacks, the company’s strong management efficiency, net-debt-free status, and growing institutional participation have contributed to a more balanced outlook for investors.

Read full news article

Supriya Lifescience Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-08-31 08:03:02

Supriya Lifescience Ltd has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse.

Read full news article

Supriya Lifescience’s Technical Shift and Downgrade Weigh on Stock Despite Long-Term Strength

2026-08-29 11:02:29

Key Events This Week

24 Aug: Stock opens at Rs.797.00, declines 0.99%

25 Aug: Downgrade to Sell announced; stock falls 0.72%

26 Aug: Technical momentum shift noted; stock drops 1.06%

27 Aug: Continued weakness; stock declines 0.86%

28 Aug: Strong recovery; stock surges 3.55%

Week Open

Rs.805.00

Read full news article

Supriya Lifescience Downgraded to Sell Amid Technical and Financial Setbacks

2026-08-26 08:29:55

Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 Aug 2026. This change reflects a combination of deteriorating technical indicators, subdued financial trends, and valuation concerns despite some positive quality metrics and institutional interest.

Read full news article

Supriya Lifescience Ltd Faces Technical Momentum Shift Amid Mixed Indicators

2026-08-26 08:05:16

Supriya Lifescience Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Recent technical indicators reveal a complex picture, with bearish signals emerging on weekly and monthly charts, while some daily metrics maintain mild bullishness. This nuanced development comes amid a modest decline in the stock price and a downgrade in its Mojo Grade from Hold to Sell, reflecting growing caution among investors.

Read full news article

Supriya Lifescience Gains 1.62%: 6 Key Factors Driving the Week’s Momentum

2026-08-22 11:02:26

Key Events This Week

17 Aug: Technical setback amid price momentum shift, stock closes at ₹784.00 (-1.04%)

18 Aug: Mixed momentum signals with sideways consolidation, stock rises to ₹802.30 (+2.33%)

19 Aug: Technical momentum shifts to mildly bullish, stock surges to ₹812.65 (+3.21%)

20 Aug: Bearish signals emerge, stock dips to ₹787.35 (-1.86%)

21 Aug: Mojo rating upgraded to Hold amid mixed signals, stock closes at ₹805.00 (+1.62%)

...

Read full news article

Supriya Lifescience Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals

2026-08-21 08:22:15

Supriya Lifescience Ltd has seen its investment rating upgraded from Sell to Hold as of 20 August 2026, reflecting a nuanced shift in its financial performance, valuation, and technical outlook. Despite recent quarterly setbacks, the company’s long-term returns and institutional interest have supported a more balanced view, prompting analysts to revise their stance cautiously.

Read full news article

View All News